309 related articles for article (PubMed ID: 33465371)
21. Zebrafish abcb11b mutant reveals strategies to restore bile excretion impaired by bile salt export pump deficiency.
Ellis JL; Bove KE; Schuetz EG; Leino D; Valencia CA; Schuetz JD; Miethke A; Yin C
Hepatology; 2018 Apr; 67(4):1531-1545. PubMed ID: 29091294
[TBL] [Abstract][Full Text] [Related]
22. The canalicular bile salt export pump BSEP (ABCB11) as a potential therapeutic target.
Stieger B; Beuers U
Curr Drug Targets; 2011 May; 12(5):661-70. PubMed ID: 21039337
[TBL] [Abstract][Full Text] [Related]
23. Hepatic gene transfer of human aquaporin-1 improves bile salt secretory failure in rats with estrogen-induced cholestasis.
Marrone J; Soria LR; Danielli M; Lehmann GL; Larocca MC; Marinelli RA
Hepatology; 2016 Aug; 64(2):535-48. PubMed ID: 26999313
[TBL] [Abstract][Full Text] [Related]
24. Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes.
Kruglov EA; Gautam S; Guerra MT; Nathanson MH
Hepatology; 2011 Nov; 54(5):1790-9. PubMed ID: 21748767
[TBL] [Abstract][Full Text] [Related]
25. An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy.
Dixon PH; Sambrotta M; Chambers J; Taylor-Harris P; Syngelaki A; Nicolaides K; Knisely AS; Thompson RJ; Williamson C
Sci Rep; 2017 Sep; 7(1):11823. PubMed ID: 28924228
[TBL] [Abstract][Full Text] [Related]
26. The choleretic role of tauroursodeoxycholic acid exacerbates alpha-naphthylisothiocyanate induced cholestatic liver injury through the FXR/BSEP pathway.
Zhao J; Song G; Weng F; Li Y; Zou B; Jin J; Yan D; Sun X; Liu C; Qiu FR
J Appl Toxicol; 2023 Jul; 43(7):1095-1103. PubMed ID: 36787806
[TBL] [Abstract][Full Text] [Related]
27. Loss of bile salt export pump aggravates lipopolysaccharide-induced liver injury in mice due to impaired hepatic endotoxin clearance.
Remetic J; Ghallab A; Hobloss Z; Brackhagen L; Hassan R; Myllys M; Radun R; Mlitz V; Zhu C; Baumgartner M; Schrottmaier WC; Mussbacher M; Timelthaler G; Scharnagl H; Stojakovic T; Assinger A; Fuchs CD; Hengstler JG; Trauner M
Hepatology; 2022 May; 75(5):1095-1109. PubMed ID: 34927748
[TBL] [Abstract][Full Text] [Related]
28. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.
Girard M; Lacaille F; Verkarre V; Mategot R; Feldmann G; Grodet A; Sauvat F; Irtan S; Davit-Spraul A; Jacquemin E; Ruemmele F; Rainteau D; Goulet O; Colomb V; Chardot C; Henrion-Caude A; Debray D
Hepatology; 2014 Jul; 60(1):301-10. PubMed ID: 24375397
[TBL] [Abstract][Full Text] [Related]
29. The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity.
Garzel B; Yang H; Zhang L; Huang SM; Polli JE; Wang H
Drug Metab Dispos; 2014 Mar; 42(3):318-22. PubMed ID: 24335466
[TBL] [Abstract][Full Text] [Related]
30. Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids.
Marschall HU; Wagner M; Bodin K; Zollner G; Fickert P; Gumhold J; Silbert D; Fuchsbichler A; Sjövall J; Trauner M
J Lipid Res; 2006 Mar; 47(3):582-92. PubMed ID: 16327028
[TBL] [Abstract][Full Text] [Related]
31. The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease.
Lam P; Soroka CJ; Boyer JL
Semin Liver Dis; 2010 May; 30(2):125-33. PubMed ID: 20422495
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the dynamic localization of the rat Bsep gene-encoded bile salt export pump by anisoosmolarity.
Schmitt M; Kubitz R; Lizun S; Wettstein M; Häussinger D
Hepatology; 2001 Mar; 33(3):509-18. PubMed ID: 11230729
[TBL] [Abstract][Full Text] [Related]
33. High-Throughput Screening to Evaluate Inhibition of Bile Acid Transporters Using Human Hepatocytes Isolated From Chimeric Mice.
Kohara H; Bajaj P; Yamanaka K; Miyawaki A; Harada K; Miyamoto K; Matsui T; Okai Y; Wagoner M; Shinozawa T
Toxicol Sci; 2020 Feb; 173(2):347-361. PubMed ID: 31722436
[TBL] [Abstract][Full Text] [Related]
34. [Bile acids in the process of canalicular bile formation].
Sinel'nik TB; Sinel'nik OD; Ribal'chenko VK
Fiziol Zh (1994); 2003; 49(6):80-93. PubMed ID: 14965044
[TBL] [Abstract][Full Text] [Related]
35. The Bile Salt Export Pump: Molecular Structure, Study Models and Small-Molecule Drugs for the Treatment of Inherited BSEP Deficiencies.
Sohail MI; Dönmez-Cakil Y; Szöllősi D; Stockner T; Chiba P
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466755
[TBL] [Abstract][Full Text] [Related]
36. Functional expression of the canalicular bile salt export pump of human liver.
Noé J; Stieger B; Meier PJ
Gastroenterology; 2002 Nov; 123(5):1659-66. PubMed ID: 12404240
[TBL] [Abstract][Full Text] [Related]
37. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
Paumgartner G; Beuers U
Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
[TBL] [Abstract][Full Text] [Related]
38. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450.
Schuetz EG; Strom S; Yasuda K; Lecureur V; Assem M; Brimer C; Lamba J; Kim RB; Ramachandran V; Komoroski BJ; Venkataramanan R; Cai H; Sinal CJ; Gonzalez FJ; Schuetz JD
J Biol Chem; 2001 Oct; 276(42):39411-8. PubMed ID: 11509573
[TBL] [Abstract][Full Text] [Related]
39. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
Funk C; Ponelle C; Scheuermann G; Pantze M
Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
[TBL] [Abstract][Full Text] [Related]
40. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
